|
|
Anavex advances second lead compound; initiates scale-up manufacturing of ANAVEX 1-41
Sources News Release
http://www.sources.com/Releases/NR1317.htm
Publisher: Anavex Life Sciences Corp.
Date Written: 08/06/2011
Year Published: 2011
Resource Type: Article
Anavex Life Sciences Corp., (“Anavex”) (OTCBB: AVXL) today announced the initiation of scale-up manufacturing of ANAVEX 1-41, its lead compound for a range of important neurological diseases and a potential back-up compound to ANAVEX 2-73 in Alzheime
Abstract: HOBOKEN, NJ, June 8, 2011 – Anavex Life Sciences Corp., (“Anavex”) (OTCBB: AVXL) today announced the initiation of scale-up manufacturing of ANAVEX 1-41, its lead compound for a range of important neurological diseases and a potential back-up compound to ANAVEX 2-73 in Alzheimer’s disease.
“This is an important step in the advancement of our second lead compound. With sufficient quantities of ANAVEX 1-41 in hand we will be in a position to advance the program and begin preclinical studies o...
To read the full release go to http://www.sources.com/Releases/NR1317.htm
Topics
|
AlterLinks
c/o Sources
© 2025.
|
|
|
|
